In an interview with the trade journal "Laborjournal", our managing directors explain how the Dynamic42 biotech chips work and how the "mini-organs" used contribute to reducing animal experiments.
An article in the MED Engineering journal explained the potential of our "mini organs" from the laboratory for drug and food testing.
Exciting answers to exciting questions: We were interviewed by bionity and analytica-world. Read it now!
Read the interview with Thomas Stölzel in WirtschaftsWoche.
Find out how our biotech chips are used in food analysis!
You want to know why we are called "Dynamic42"? Take a look at our feature on MDR Thüringen!
At the award ceremony for the XXIII Thuringian Innovation Prize, we were interviewed about our development for the Ostthüringer Zeitung newspaper.
Dynamic42 GmbH has closed a seven-figure start-up financing round - Read more about
We participate in the EU project to develop innovative model systems for the evaluation of immunomodulatory therapeutics.
The first seed financing in the six-figure range was closed in early summer 2019.